Abstract
The sensitivity to anticonvulsants and anesthetics of Ca2+currents arising from α1G and α1H subunits was examined in stably transfected HEK293 cells. For comparison, in some cases blocking effects on dorsal root ganglion (DRG) T currents were also examined under identical ionic conditions. The anticonvulsant, phenytoin, which partially blocks DRG T current, blocked α1G current completely but with weaker affinity (∼140 μM). Among different cells, α1H current exhibited either of two responses to phenytoin. In one subpopulation of cells, phenytoin produced a partial, higher affinity block (IC50 ∼7.2 μM, maximum block ∼43%) similar to that in DRG neurons. In other cells, phenytoin produced complete, but lower affinity, blockade (IC50 ∼138 μM, maximum block ∼89%). Another anticonvulsant, α-methyl-α-phenylsuccinimide (MPS), blocked DRG current partially, but blocked both α1G and α1H currents completely with weaker affinity (∼1.7 mM). These data suggest that higher affinity blockade of T-type currents by phenytoin and MPS may require additional regulatory factors that can contribute to native T-type channels. In contrast, anesthetics blocked all T current variants similarly and completely. Block of α1G current by anesthetics had the following order of potency: propofol (IC50 ∼20.5 μM) > etomidate (∼161 μM) = octanol (∼160 μM) > isoflurane (∼277 μM) > ketamine (∼1.2 mM), comparable with results on DRG T currents. Barbiturates completly blocked α1G currents with potency [thiopental (∼280 μM), pentobarbital (∼310 μM), phenobarbital (∼1.54 mM)] similar to that in DRG cells. The effects of propofol, octanol, and pentobarbital on α1H currents were indistinguishable from effects on α1G currents.
Footnotes
- Received December 1, 1999.
- Accepted March 14, 2000.
-
Send reprint requests to: Christopher Lingle, Department of Anesthesiology, Washington University School of Medicine, Box 8054, St. Louis, MO 63110. E-mail:clingle{at}morpheus.wustl.edu
-
This work was supported by National Institutes of Health Grants GM-47969 (to C.L.) and HL58728 (to E.P.R.). S.T. was the recipient of a Foundation for Anesthesia Education and Research/Abbott Laboratories New Investigator Award.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|